Xiangxue Pharmaceutical Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 12, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020
Market Capitalization	6,322	6,461	3,406	3,961	5,266	5,842
Market Cap Growth	-6.37%	89.71%	-14.02%	-24.79%	-9.85%	1.02%
Enterprise Value	8,819	9,128	6,159	6,816	9,064	9,617
Last Close Price	9.56	9.77	5.15	6.07	8.07	8.95
PE Ratio	-	-	-	-	-	59.36
Forward PE	-	11.93	11.93	11.93	11.93	11.93
PS Ratio	4.30	3.48	1.48	1.81	1.77	1.90
PB Ratio	5.75	4.49	1.47	1.46	1.40	1.38
P/TBV Ratio	-	437.03	4.23	3.47	3.20	3.07
P/FCF Ratio	103.68	-	16.42	-	-	-
P/OCF Ratio	77.46	355.48	12.93	17.42	20.45	22.72
EV/Sales Ratio	6.00	4.91	2.68	3.12	3.05	3.13
EV/EBITDA Ratio	-	-	21.82	113.06	72.50	21.51
EV/EBIT Ratio	-	-	123.98	-	-	30.84
EV/FCF Ratio	144.63	-	29.69	-	-	-
Debt / Equity Ratio	2.02	1.56	1.05	0.90	0.92	0.93
Debt / EBITDA Ratio	-	-	8.48	38.38	27.04	8.86
Debt / FCF Ratio	36.36	-	11.73	-	-	-
Net Debt / Equity Ratio	1.90	1.46	0.99	0.84	0.82	0.78
Net Debt / EBITDA Ratio	-17.14	-133.61	8.09	38.01	24.64	7.38
Net Debt / FCF Ratio	34.30	-122.94	11.01	-16.38	-10.10	-6.61
Asset Turnover	0.19	0.24	0.27	0.22	0.25	0.30
Inventory Turnover	3.28	3.86	3.54	2.69	2.78	2.62
Quick Ratio	0.18	0.19	0.19	0.18	0.28	0.39
Current Ratio	0.27	0.30	0.35	0.32	0.44	0.55
Return on Equity (ROE)	-62.41%	-45.91%	-15.96%	-15.58%	-16.45%	3.39%
Return on Assets (ROA)	-2.67%	-1.85%	0.37%	-1.09%	-0.12%	1.89%
Return on Invested Capital (ROIC)	-10.06%	-5.75%	1.03%	-2.96%	-0.31%	3.85%
Return on Capital Employed (ROCE)	-25.00%	-11.10%	1.60%	-5.10%	-0.50%	5.80%
Earnings Yield	-15.86%	-13.29%	-11.42%	-13.38%	-13.07%	1.69%
FCF Yield	0.96%	-0.26%	6.09%	-3.53%	-5.79%	-8.54%
Payout Ratio	-	-	-	-	-	208.23%
Buyback Yield / Dilution	-0.41%	-0.18%	0.50%	-0.09%	-0.89%	-2.90%
Total Shareholder Return	-0.41%	-0.18%	0.50%	-0.09%	-0.89%	-2.90%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.